Sat 28 Nov 2009 | 23:47 EST

You are here: Home > Business & Finance > Stocks > Officers and Directors

Do More With Reuters

Partner Services

Affiliate Network

Professional Products

Support (Customer Zone)

Financial Products

About Thomson Reuters

Officers and Directors For ARYx Therapeutics, Inc.

ARYx Therapeutics, Inc. (ARYX.O) (Consolidated Issue listed on NASDAQ Global Market)

sector: Healthcare . industry: Biotechnology · View ARYX on other exchanges

As of 27 Nov 2009

2.71USD

Price Change

-0.10

Percent Change

-3.56%

Analyst Recommendations

Independent Research | Broker Research

Name	Total Annual Compensation	Long-Term Incentive Plans	All Other	Fiscal Year Total
As Of 30 Dec 2008
Beier, David	--	--	--	--
Canafax, Daniel	263,724	--	10,611	469,475
Druzgala, Pascal	270,555	--	147,639	418,194
Ekman, Lars	--	--	--	--
Goddard, Paul	437,850	--	398,806	856,927
Leonard, Keith	--	--	--	--
Milner, Peter	323,294	--	138,595	461,889
Nagler, David	343,048	--	3,704	346,752
Rosenman, Herm	--	--	--	--
Sekhri, Paul	--	--	--	--
Simon, Nicholas	--	--	--	--
Varian, John	314,774	--	147,576	462,350

Find out more about ARYX.O

Insider Trading

Reuters.com: Help and Contact Us | Advertise With Us | Mobile | Newsletters | RSS | Labs | Journalism Handbook | Archive | Site Index | Video Index

Thomson Reuters Corporate: Copyright | Disclaimer | Privacy | Professional Products | Professional Products Support | About Thomson Reuters | Careers

International Editions: Africa | Arabic | Argentina | Brazil | Canada | China | France | Germany | India | Italy | Japan | Latin America | Mexico | Russia | Spain | United Kingdom | United States

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.